PRISM MarketView, Stock Market, Healthcare, PRISM DigitalMedia, Pharmaceutical, PRISM MediaWire, NASDAQ, Oncology, OCX Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays Thomas Wolff Dec 6, 2023 10:33:17 AM Read more
PRISM MarketView, Stock Market, PRISM DigitalMedia, Pharmaceutical, PRISM MediaWire, NASDAQ, Oncology, OCX Oncocyte Reports Third Quarter 2023 Financial Results Thomas Wolff Nov 9, 2023 1:49:41 PM Read more